NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Follow-Up Questions
NetraMark Holdings Inc 的 CEO 是誰?
Mr. George Achilleos 是 NetraMark Holdings Inc 的 President,自 2021 加入公司。
AINMF 股票的價格表現如何?
AINMF 的當前價格為 $0.8636,在上個交易日 decreased 了 0%。
NetraMark Holdings Inc 的主要業務主題或行業是什麼?
NetraMark Holdings Inc 屬於 Health Care 行業,該板塊是 Health Care